1943 results
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
trials with the FDA ... EBM #Psychiatry #NegativeTrials ... Bias #Comparison #FDA
Trial of Solanezumab for Mild Dementia Due to Alzheimers Disease #EBM #Dementia #Solanezumab #Alzheimers #NegativeTrial #VisualAbstract
Solanezumab #Alzheimers #NegativeTrial
History of Systemic Thrombolysis for Ischemic Stroke and Benefit in Neurologic Outcomes - Salim R. Rezaie
Neurology #Stroke #NegativeTrials
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
trials with the FDA ... EBM #Psychiatry #NegativeTrials ... Bias #Comparison #FDA
With the recent publication of the FDA Guidance on alcohol-based hand sanitizer compounding, I thought to
publication of the FDA ... with both the FDA ... FDA is also encouraging
Thrombolytics for stroke: The evidence - 
A summary of the evidence for (or against) thrombolytics for
EBM #Neurology #NegativeTrials
ADA 2020 Diabetes #management #algorithm #treatment
ADA 2020 Diabetes ... #management #algorithm
Alprazolam - short-acting benzodiazepine (GABA Receptor Modulator) used in the treatment of anxiety disorders. FDA approved
FDA approved in
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
FDA recommends, ... ADA/KDIGO Consensus ... Diabetes #CKD #ADA
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
approved by the FDA